logo

Qualigen Therapeutics, Inc. (QLGN)



Trade QLGN now with
  Date
  Headline
6/7/2022 9:15:03 AM Qualigen Announces IND-Enabling Studies To Advance Lead Program QN-302 Toward Clinical Trials
5/13/2022 6:25:26 AM Qualigen Therapeutics Q1 Net Loss $4.3 Mln Or $0.12/Shr Vs Loss Of $5.2 Mln Or $0.19/Shr Last Year
5/3/2022 9:34:36 AM Qualigen Therapeutics To Acquire Majority Stake In NanoSynex
1/26/2021 9:20:30 AM Qualigen Completes Milestone Related To License And Tech Transfer Of FastPack Diagnostics Products In China